Skip to main content

Loading market data...

CAH

Cardinal Health, Inc.

NYSE • United states

Quote unavailable

No current sourced quote was returned.

Management
Credibility
Score

Cardinal Health, Inc. (CAH)

Unavailable

Quotes may be delayed

Unavailable

Market Cap

Unavailable

Volume

Unavailable

P/E Ratio

0.81%

Div Yield

Cardinal Health, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 7000 CARDINAL PLACE, DUBLIN, OH
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

1 Oct 2026

Cardinal Health, Inc. reported Regulation FD disclosure

Cardinal Health, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

21 Sep 2026

Cardinal Health, Inc. proxy and shareholder-vote filing

Cardinal Health, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.

21 Sep 2026

Cardinal Health, Inc. proxy and shareholder-vote filing

Cardinal Health, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.

13 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Cardinal Health, Inc..

11 Aug 2026

Cardinal Health, Inc. filed Form 10-K

Cardinal Health, Inc. submitted Form 10-K to the SEC for the period ending Jun 30, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$4.86B

Total assets (USD)$57.30B

Shareholders' equity (USD)−$2.88B

Long-term debt (USD)$2.50B

Debt due within a year (USD)$345.50M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q4 2025	$65.63B	$707.00M	$467.00M	Unavailable	10-Q · 5 Feb 2026
Q3 2025	$64.01B	$668.00M	$450.00M	$1.88	10-Q · 30 Oct 2025
Q1 2025	$54.88B	$730.00M	$506.00M	Unavailable	10-Q · 1 May 2025
Q4 2024	$55.26B	$549.00M	$400.00M	Unavailable	10-Q · 30 Jan 2025
Q3 2024	$52.28B	$568.00M	$416.00M	$1.70	10-Q · 1 Nov 2024
Q1 2024	$54.87B	$369.00M	$261.00M	$1.07	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $275.08

Upside unavailable

📈

Strong Buy

Unavailable

👍

Buy

11

⏸️

Hold

2

📉

Sell

0

13 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 20:47 UTC Targets range 255.00–295.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

19

Aug 2026

Scherer Mary C.

Chief Accounting Officer

Open-market sale

$237.39 per share

2,302 shares

19

Aug 2026

Hollar Jason M.

Chief Executive Officer

Open-market sale

$236.18 per share

44,529 shares

18

Aug 2026

Hollar Jason M.

Chief Executive Officer

Open-market sale

$235.74 per share

80,000 shares

18

Aug 2026

Mason Stephen M

CEO, GMPD Segment

Open-market sale

$236.40 per share

35,000 shares

18

Aug 2026

WEITZMAN DEBORAH

CEO, PSS Segment

Open-market sale

$235.45 per share

7,354 shares

18

Aug 2026

Alt Aaron E

Chief Financial Officer

Open-market sale

$236.34 per share

42,000 shares

18

Aug 2026

Mayer Jessica L

Chief Legal/Compliance Officer

Open-market sale

$236.19 per share

29,436 shares

18

Aug 2026

Greene Michelle D.

Chief Information Officer

Open-market sale

$235.72 per share

11,650 shares

15

Aug 2026

WEITZMAN DEBORAH

CEO, PSS Segment

Grant or award

Unavailable per share

7,314 shares

15

Aug 2026

WEITZMAN DEBORAH

CEO, PSS Segment

Tax withholding

$235.17 per share

29,759 shares

Top Shareholders

Vanguard Group Inc

31,441,258 shares

2.004% change

12/31/2025

Blackrock, Inc.

26,490,633 shares

-7.034% change

6/30/2026

Vanguard Capital Management Llc

15,292,186 shares

0.023% change

6/30/2026

Wellington Management Group Llp

14,860,271 shares

247.515% change

6/30/2026

Vanguard Portfolio Management Llc

13,717,894 shares

-0.105% change

6/30/2026

State Street Corp

11,967,121 shares

-0.889% change

6/30/2026

Geode Capital Management, Llc

6,472,810 shares

-1.637% change

6/30/2026

Invesco Ltd.

4,742,576 shares

35.03% change

6/30/2026

Morgan Stanley

4,625,329 shares

-6.641% change

6/30/2026

Wcm Investment Management, Llc

4,112,461 shares

2.641% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 20:47 UTC· 1 day ago

Research coverage and investment tools

Cardinal Health, Inc. (CAH) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Other Pharmaceuticals). It paid US$2.05 a share in dividends over the last 12 months, a dividend yield of 0.81%. The latest ex-dividend date on file is 1 Oct 2026.

Watch Add to portfolio Set an alert Compare

Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q4 2025	$65.63B	$707.00M	$467.00M	Unavailable	3.7%	1.1%	—	10-Q · 5 Feb 2026 (opens in a new tab)
Q3 2025	$64.01B	$668.00M	$450.00M	$1.88	3.6%	1.0%	$865.00M	10-Q · 30 Oct 2025 (opens in a new tab)
Q1 2025	$54.88B	$730.00M	$506.00M	Unavailable	3.9%	1.3%	—	10-Q · 1 May 2025 (opens in a new tab)
Q4 2024	$55.26B	$549.00M	$400.00M	Unavailable	3.5%	1.0%	—	10-Q · 30 Jan 2025 (opens in a new tab)
Q3 2024	$52.28B	$568.00M	$416.00M	$1.70	3.6%	1.1%	−$1.74B	10-Q · 1 Nov 2024 (opens in a new tab)
Q1 2024	$54.87B R (restated)	$369.00M R (restated)	$261.00M R (restated)	$1.07	3.5%	0.7%	—	10-Q · 1 May 2025 (opens in a new tab)

Cash and equivalents: $4.86B
Total assets: $57.30B
Shareholders' equity: −$2.88B
Long-term debt: $2.50B
Debt due within a year: $345.50M

8-K · 1 Oct 2026

Cardinal Health, Inc. reported Regulation FD disclosure (opens in a new tab)

Cardinal Health, Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
DEFA14A · 21 Sep 2026

Cardinal Health, Inc. proxy and shareholder-vote filing (opens in a new tab)

Cardinal Health, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.
DEF 14A · 21 Sep 2026

Cardinal Health, Inc. proxy and shareholder-vote filing (opens in a new tab)

Cardinal Health, Inc. filed materials concerning shareholder voting, governance, director elections or executive compensation.
SCHEDULE 13G · 13 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Cardinal Health, Inc..
10-K · 11 Aug 2026

Cardinal Health, Inc. filed Form 10-K (opens in a new tab)

Cardinal Health, Inc. submitted Form 10-K to the SEC for the period ending Jun 30, 2026.

Insider	Date	Transaction	Shares	Average price	Filing
Scherer Mary C. Chief Accounting Officer	19 Aug 2026	Open-market sale (S)	−2,302	$237.39	Form 4 (opens in a new tab)
Hollar Jason M. Chief Executive Officer	19 Aug 2026	Open-market sale (S)	−44,529	$236.18	Form 4 (opens in a new tab)
Hollar Jason M. Chief Executive Officer	18 Aug 2026	Open-market sale (S)	−80,000	$235.74	Form 4 (opens in a new tab)
Mason Stephen M CEO, GMPD Segment	18 Aug 2026	Open-market sale (S)	−35,000	$236.40	Form 4 (opens in a new tab)
WEITZMAN DEBORAH CEO, PSS Segment	18 Aug 2026	Open-market sale (S)	−7,354	$235.45	Form 4 (opens in a new tab)
Alt Aaron E Chief Financial Officer	18 Aug 2026	Open-market sale (S)	−42,000	$236.34	Form 4 (opens in a new tab)
Mayer Jessica L Chief Legal/Compliance Officer	18 Aug 2026	Open-market sale (S)	−29,436	$236.19	Form 4 (opens in a new tab)
Greene Michelle D. Chief Information Officer	18 Aug 2026	Open-market sale (S)	−11,650	$235.72	Form 4 (opens in a new tab)
WEITZMAN DEBORAH CEO, PSS Segment	15 Aug 2026	Grant or award (A)	+7,314	—	Form 4 (opens in a new tab)
WEITZMAN DEBORAH CEO, PSS Segment	15 Aug 2026	Tax withholding (F)	−29,759	$235.17	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	31,441,258	2.004%
Blackrock, Inc.	6/30/2026	26,490,633	-7.034%
Vanguard Capital Management Llc	6/30/2026	15,292,186	0.023%
Wellington Management Group Llp	6/30/2026	14,860,271	247.515%
Vanguard Portfolio Management Llc	6/30/2026	13,717,894	-0.105%
State Street Corp	6/30/2026	11,967,121	-0.889%
Geode Capital Management, Llc	6/30/2026	6,472,810	-1.637%
Invesco Ltd.	6/30/2026	4,742,576	35.03%
Morgan Stanley	6/30/2026	4,625,329	-6.641%
Wcm Investment Management, Llc	6/30/2026	4,112,461	2.641%

Average volume: 2,303,844
EPS (FY 2026, diluted): 7.23 USD
Dividends (last 12 months): 2.05 USD
Dividend yield: 0.81%
Ex-dividend date: 1 Oct 2026
Shares outstanding: 231.56M
Beta (5Y monthly): 0.53

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:26 UTC· 7 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:26 UTC· 7 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. What dividend yield leaves out: dividend yield vs total return

This research is not available for CAH yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.